In short. How herpes simplex is diagnosed with modern testing, what triggers recurrences, the treatment classes that shorten and suppress outbreaks, and what cannot be cured.

Key points

  • A negative swab from a sore that is already healing may simply mean the sample was taken too late, not that herpes is absent.
  • Antibody tests taken too early after exposure can be negative while infection is present.
  • Interpreting these results correctly is a specialist skill, and incorrect interpretation causes a great deal of unnecessary distress.

Herpes simplex virus is a common, lifelong infection with two main types. Type 1 typically causes cold sores around the mouth and is usually acquired in childhood; type 2 typically causes genital infection and is usually transmitted sexually. The distinction is not absolute, and either type can appear in either site. After the first infection the virus travels to a nerve ganglion and remains there, which is why outbreaks recur and why the infection cannot be eradicated.

What an outbreak looks like

The first episode is often the most severe, with painful blisters, sores, fever, and swollen lymph nodes. Recurrences are usually milder and shorter, and are often preceded by a warning tingling. Triggers include illness, fever, sunlight, menstruation, fatigue, and physical or emotional stress. Importantly, the virus can be shed from the skin without any visible sore, which is how most transmission occurs.

How the diagnosis is confirmed

A visible outbreak can often be recognised clinically, but confirmation matters, because other conditions produce identical ulcers. A swab from the base of a fresh blister sent for viral DNA testing is the most sensitive method and is far more reliable than older culture techniques. Blood antibody testing has a specific but limited role: it can show whether someone has been infected with either type, but it cannot tell where the infection is or when it was acquired, and it is unhelpful during an active outbreak. In recurrent or atypical cases, and when the diagnosis remains uncertain, referral to a specialist clinic is appropriate.

Testing has limits worth understanding

A negative swab from a sore that is already healing may simply mean the sample was taken too late, not that herpes is absent. Antibody tests taken too early after exposure can be negative while infection is present. Interpreting these results correctly is a specialist skill, and incorrect interpretation causes a great deal of unnecessary distress. Testing is best done at the right moment, on the right sample, and explained properly.

Treatment classes

Antiviral medicines in the nucleoside analogue class are the mainstay. Taken at the first tingle they shorten and soften an outbreak; taken continuously at a lower dose they suppress recurrences, which is appropriate for people who have frequent, disruptive outbreaks. Pain relief, salt-water rinsing, and simple barrier measures help during an episode. Antiviral treatment started late in an outbreak helps far less, which is why it is supplied in advance for people who recognise their warning signs.

Follow-up and honest limits

Antiviral therapy controls outbreaks; it does not remove the virus, and outbreaks may still occur at a reduced rate. Suppressive therapy is usually reviewed after a year, because recurrence patterns change over time. Relevant screening for other infections is offered at the same time, since the risk factors overlap.

Seek medical care promptly if

  • Sores affect the eye or eyelid, or there is eye pain, redness, or blurred vision — ocular infection can threaten sight and needs urgent specialist review.
  • Someone with eczema develops widespread painful blisters or eroded skin with fever — this is a serious complication requiring immediate treatment.
  • An outbreak occurs in pregnancy near term, or in a newborn baby, or in someone with weakened immunity — specialist assessment is needed without delay.

Related reading

Frequently asked questions

How is herpes simplex confirmed?

A swab taken from the base of a fresh blister and sent for viral DNA testing, which is far more sensitive than older culture methods. Blood antibody testing has a limited role: it can show whether someone has been infected with either type, but not where or when.

Can herpes simplex be cured?

No. Antiviral therapy controls outbreaks but does not remove the virus, which remains in a nerve ganglion and can reactivate. Suppressive therapy reduces how often outbreaks occur and is usually reviewed after a year, because recurrence patterns change over time.

How are recurrent outbreaks managed?

Antiviral medicines taken at the first tingle shorten and soften an outbreak, so they are supplied in advance for people who recognise their warning signs. Taken continuously at a lower dose, the same class suppresses recurrences for those whose outbreaks are frequent and disruptive.

Risks & Limitations

  • Most chronic skin disease is managed rather than cured, and relapse is expected.
  • Treatments typically need 8–12 weeks before response can be judged fairly.
  • Topical treatment can cause irritation, dryness, peeling and photosensitivity.
  • Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
  • Isotretinoin in particular requires strict monitoring and pregnancy prevention.
  • Pigment change is often slow and may be incomplete.
  • No treatment works for everyone, and response cannot be predicted with certainty.

When to Seek Care

  • A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
  • Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
  • Rapidly spreading redness, swelling or pain in the skin.
  • Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
  • New or worsening symptoms while taking a monitored medication.

References & Further Reading

  • American Academy of Dermatology (AAD) — public and clinical guidance
  • World Health Organization (WHO) — skin and infectious disease resources
  • Chinese Medical Association, Dermatology Branch — clinical guidance
  • Cochrane Library — systematic reviews in dermatology

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.